Paragon 28, Inc. Overview
Pro stress-test →Paragon 28 is a leading medical device company focused exclusively on the foot and ankle orthopedic space. Zimmer Biomet completed its acquisition of Paragon 28 on April 21, 2025, and the company became a wholly-owned subsidiary of Zimmer Biomet. The acquisition was valued at approximately $1.2 billion enterprise value.
Strategic Profile
Pro stress-test →Paragon 28 provides innovative orthopedic solutions, procedural approaches and instrumentation covering a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD), flatfoot, Charcot foot and orthobiologics. The global market for implants and devices used in foot and ankle procedures is projected to grow at approximately 7% annually to reach $6.9 billion by 2028, representing the fastest-growing market within orthopedics.
Competitive Landscape
Pro stress-test →Paragon 28 competes with multinational companies such as Stryker, Arthrex, Smith & Nephew, Johnson & Johnson and Zimmer Biomet, as well as companies with one or a limited number of foot and ankle products such as Enovis, Medline, Conmed, and Treace Medical Concepts. Now operating as a Zimmer Biomet subsidiary, the company benefits from integration with a broader orthopedic portfolio while maintaining focus on its specialty.
Industry Context
Paragon 28, Inc. operates in Orthopedic Medical Devices.
Key facts
Founded: 2010 · Headquarters: Englewood, Colorado